Bart Geers

Bart Geers is an experienced investment manager at KU Leuven since June 2018. Additionally, Bart serves as a board member for various companies, including Tavira Therapeutics, AstriVax, Pulsify Medical, FOx Biosystems, and Augustine Therapeutics, and holds the position of Chairman of the Board for RegMed XB Flanders VZW. Prior to these roles, Bart worked as a Senior Scientist and Valorisation Manager at Ghent University and managed the Center for Nano and Biophotonics from August 2013 to May 2018. Bart's early career includes a role as a Quality Engineer at Alcon and an academic assistant at Ghent University. Educational qualifications include a Doctor of Philosophy in Pharmacy and a Master in Pharmaceutical Sciences, both from Ghent University, complemented by a secondary education focused on Latin and Mathematics.